Post-hematopoietic cell transplantation control of graft-versus-host disease by donor CD4+25+ T cells to allow an effective graft-versus-leukemia response

Biology of Blood and Marrow Transplantation

Volumn 9, Issue 4, 2003, Pages 243-256

  Jones, Stephen C ^a   Murphy, George F ^b   Korngold, Robert ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Graft versus leukemia; Graft versus host disease; Hematopoietic cell transplantation; Regulation

Indexed keywords

INTERLEUKIN 2; MINOR HISTOCOMPATIBILITY ANTIGEN;

ADOPTIVE IMMUNOTHERAPY; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ALLOIMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ISOLATION; CONTROLLED STUDY; DONOR; DRUG MEGADOSE; FATALITY; GRAFT VERSUS HOST REACTION; GRAFT VERSUS LEUKEMIA EFFECT; IMMUNE RESPONSE; IMMUNOREGULATION; IN VITRO STUDY; INFECTION CONTROL; LEUKEMIA CELL; LEUKEMIA CELL LINE; MAJOR HISTOCOMPATIBILITY COMPLEX; MYELOID LEUKEMIA; NONHUMAN; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; GRAFT VS HOST DISEASE; GRAFT VS LEUKEMIA EFFECT; HAPLOTYPES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; LYMPHOCYTE TRANSFUSION; MAJOR HISTOCOMPATIBILITY COMPLEX; MICE; MICE, INBRED STRAINS; MODELS, ANIMAL; RECEPTORS, INTERLEUKIN-2; TRANSPLANTATION, HOMOLOGOUS;

EID: 0242557055     PISSN: 10838791     EISSN: None     Source Type: Journal    
DOI: 10.1053/bbmt.2003.50027     Document Type: Article

References (58)

1. + naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self tolerance J Immunol 162 1999 5317-5326.
2. Asano M Toda M Sakaguchi N Sakaguchi S. Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation J Exp Med 184 1996 387-396.
3. + T cells as a functionally and phenotypically distinct immunoregulatory T cell subpopulation Int Immunol 12 2000 1145-1155.
4. + naturally anergic and suppressive T cells: Induction of autoimmune disease by breaking their anergic/suppressive state. Int. Immunol. 10 1998 1969-1980.
5. + immunoregulatory T cell is antigen nonspecific J Immunol. 164 2000 183-190.
6. + regulatory T cells induced by an agonist self peptide Nat Immunol 2 2001 301-306.
7. + T cells J Immunol 168 2002 613-620.
8. Reiser J-B Darnault C Guimezanes A et al. Crystal structure of a T cell receptor bound to an allogeneic MHC molecule Nat Immunol 1 2000 291-297.
9. Hara M Kingsley CI Niimi M et al. IL-10 is required for regulatory T cell to mediate tolerance to alloantigens in vivo J Immunol 166 2001 3789-3796.
10. + regulatory T cells prevent graft rejection: CTLA-4 and IL-10-dependent immunoregulation of alloresponses J Immunol 168 2002 1080-1086.
11. + cells regulate CD8 cell anergy in neonatal tolerant mice Transplantation 68 1999 1891-1897.
12. Johnson BD Becker EE Labelle JL Truitt RL. Role of immunoregulatory donor T cells in suppression of graft-versus-host disease following donor leukocyte infusion J Immunol 12 1999 6479-6487.
13. + immune regulatory cells are required for induction of tolerance to alloantigens via costimulatory blockade J Exp Med 193 2001 1311-1317.
14. Horowitz MM Gale RP Sondel PM et al. Graft-versus-leukemia reactions after bone marrow transplantation. Blood 75 1990 555-562.
15. Perreault C Roy DC Fortin C. Immunodominant minor histocompatibility antigens: The major ones. Immunol Today 19 1998 69-74.
16. Baumbach WR Keath EJ Cole MD. A mouse c-myc retrovirus transforms established fibroblast lines in vitro and induces monocyte-macrophage tumors in vivo J Virol 59 1986 276-283.
17. Bruce J Symington FW McKearn TJ Sprent J. A monoclonal antibody discriminating between subsets of T and B cells J Immunol 127 1981 2496-2501.
18. Sarmiento M Glasebrook AL Fitch FW. IgG or IgM monoclonal antibodies reactive with different determinants on the molecular complex bearing Lyt-2 antigen block T cell mediated cytolysis in the absence of complement J Immunol 125 1980 2665-2672.
19. Ceredig R Lowenthal JW Nabholz M MacDonald HR. Expression of interleukin-2 receptors as a differentiation marker on intrathymic stem cells Nature 314 1985 98-100.
20. + T cell responses to minor histocompatibility antigens involved in graft-versus-host disease: Correlations with epithelial infiltrate. Biol. Blood Marrow Transplant. 7 2001 2-13.
21. Yoo YH Gilliam AC Whitaker-Menezes D Korngold R Murphy GF. Experimental induction and ultrastructural characterization of apoptosis in murine acute cutaneous graft-versus-host disease Arch Dermatol Res 289 1997 389-398.
22. + immune regulatory cells inhibits graft-versus-host disease lethality Blood 99 2002 3493-3499.
23. Korngold R Leighton C Manser T. Graft-versus-myeloid responses following sygeneic and allogeneic bone marrow transplantation Transplantation 58 1994 278-287.
24. Johnson BD Truitt Rl. A decrease in graft-vs-host disease without loss of graft-vs-leukemia reactivity after MHC-matched bone marrow transplantation by selective depletion of donor NK cells in vivo Transplantation 54 1992 104-112.
25. Aizawa S Kamisaku H Sado T. An MHC-compatible allogeneic bone marrow donor with a distinct role of T cell subsets in graft-versus-leukemia effect and lethal graft-versus-host disease. Bone Marrow Transplant 16 1995 603-609.
26. + T cells while preserving CD4- and CD8-mediated graft-versus-leukemia effects Blood 83 1994 2560-2569.
27. Yang YG Sykes M. The role of interleukin-12 in preserving the graft-versus-leukemia effect of allogeneic CD8 T cells independently of GVHD Leuk Lymphoma 33 1999 409-420.
28. Krijanovski OI Hill GR Cooke KR et al. Keratinocyte growth factor separates graft-versus-leukemia effects from graft-versus-host disease Blood 94 1999 825-831.
29. Teshima T Hill GR Pan L et al. IL-11 separates graft-versus-leukemia effects from graft-versus-host disease after bone marrow transplant J Clin Invest 104 1999 317-325.
30. Leshem B Vourka-Karussis U Slavin S. Correlation between enhancement of graft-vs-leukemia effects following allogeneic bone marrow transplantation by rIL-2 and increased frequency of cytotoxic T-lymphocyte-precursors in murine myeloid leukemia. Cytokine Cell Molec Ther 6 2000 141-147.
31. + Tc1/Tc2 populations in murine GVL: Type I cells generate GVL and type II cells abrogate GVL Biol Blood Marrow Transplant 2 1996 118-125.
32. Tsukada N Kobata T Aizawa Y Yagita H Okumura K. Graft-versus-leukemia effect and graft-versus-host disease can be differentiated by cytotoxic mechanisms in a murine model of allogeneic bone marrow transplantation Blood 93 1999 2738-2747.
33. Schmaltz C Alpdogan O Horndasch KJ et al. Differential use of fas ligand and perforin cytotoxic pathways by donor T cells in graft-versus-host disease and graft-versus-leukemia effect Blood 97 2001 2886-2895.
34. Hsieh MH Varadi G Flomenberg N Korngold R. Leucyl-leucine Methyl Ester-treated haploidentical donor lymphocyte infusions can mediate graft-versus-leukemia activity with minimal graft-versus-host disease risk Biol Blood Marrow Transplant 8 2002 303-315.
35. Johnson BD McCabe C Hanke CA Truitt RL. Use of anti-CD3e F(ab′)2 fragments in vivo modulate graft-versus-host disease without loss of graft-versus-leukemia reactivity after MHC-matched bone marrow transplantation. J. Immunol. 154 1995 5542-5554.
36. Drobyski WR Morse HC III Burns WH Casper JT Sanford G. Protection from lethal murine graft-versus-host disease without compromise of alloengraftment using transgenic donor T cells expressing a thymidine kinase suicide gene. Blood 97 2001 2506-2513.
37. + T cells provides graft-versus-leukemia responses with minimization of graft-versus-host disease following murine hematopoietic stem cell transplantation Biol Blood Marrow Transplant. 7 2001 187-196.
38. Weiden PL Flournoy N Thomas ED et al. Antileukmic effect of graft-versus-host disease in human recipients of allogeneic bone marrow grafts N Engl J Med 300 1979 1068-1073.
39. Weiden PL Sullivan KM Flournoy N Storb R Thomas ED Antileukemic effect of chronic graft-versus-host disease: Contribution to improved survival after allogeneic marrow transplants N Engl J Med 304 1981 1529-1533.
40. Sullivan KM Weiden PL Storb R et al. Influence of acute and chronic graft-versus-host disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment of acute and chronic leukemia. Blood 73 1989 1720-1728.
41. Storb R. Graft rejection and graft-versus-host disease in marrow transplantation Transplant Proc 21 1989 2915-2918.
42. Slavin S Ackerstein A Naparstek E Or R. Weiss L. The graft-versus-leukemia phenomenon: Is GVL separable from GVHD? Bone Marrow Transplant. 6 1990 155-161.
43. + T regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function J Exp Med 193 2001 1295-1301.
44. + thymocytes and peripheral T cells have immune suppressive activity in vitro Eur J Immunol 31 2001 1247-1254.
45. +CD25high regulatory cells in human peripheral blood J Immunol 167 2001 1245-1253.
46. + regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation J Exp Med 196 2002 389-399.
47. + immunoregulatory T cells:nEw therapeutics for graft-versus-host disease J Exp Med 196 2002 401-406.
48. de Camargo FG Olivares-Olivares-Villagomez D Currotto De Lafaille MA Wensky AK Latkowski JA Lafaille JJ. Regulatory T cells in spontaneous autoimmune encephalomyelitis Immunol Rev 182 2001 122-134.
49. Sykes M Romick ML Hoyles KA Sachs DH. In vivo administration of interleukin 2 plus T cell-depleted syngeneic marrow prevents graft-versus-host disease mortality and permits alloengraftment J Exp Med 171 1990 481-490.
50. Yang Y Sergio J Pearson D Szot G Shimizu A Sykes M Interleukin-12 preserves the graft-versus-leukemia effect of allogeneic CD8 T cells while inhibiting CD4-dependent graft-versus-host disease in mice Blood 90 1997 4651-4660.
51. + T cell activity J Immunol 150 1993 197-205.
52. + T cells while preserving CD4- and CD8-mediated graft-versus-leukemia effects Blood 83 1994 2560-2569.
53. Krenger W Ferrara JL. Graft-versus-host disease and the Th1/Th2 paradigm Immunol. Res 15 1996 50-73.
54. Song HK Noorchashm H Lieu YK et al. Cutting edge: Alloimmune responses against major and minor histocompatibility antigens: distinct division kinetics and requirement for CD28 costimulation J Immunol 162 1999 2467-2471.
55. + suppressor T cells in vivo Nat Immunol 3 2002 33-41.
56. + T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells J Immunol 160 1998 12-18.
57. Seddon B Mason D. Peripheral autoantigen induces regulatory T cells that prevent autoimmunity J Exp Med 189 1999 877-882.
58. Garza KM Agersborg SS Baker E Tung KS Persistence of physiological self antigen is required for the regulation of self tolerance J Immunol 164 2000 3982-3989.